摘要 |
The invention relates to sulphonamidoanilines of formula (I) wherein A is N or CH, W, X, Y and Z are N or CH under the proviso that at least one of the three symbols W, X and Y represent CH, R<SUP>1</SUP> represents NR<SUB>4</SUB>R<SUB>5</SUB> or OR<SUB>4</SUB>, wherein R<SUB>4</SUB> represents optionally substituted alkyl, optionally substituted cycloalkyl optionally comprising one or two nitrogen or oxygen atoms, or substituted aryl, and R<SUB>5</SUB> represents hydrogen or unsubstituted or substituted alkyl, or R<SUB>4</SUB> and R<SUB>5</SUB> together with the nitrogen to which they are attached represent an optionally substituted five- or six-membered nitrogen containing monocyclic ring, an optionally substituted nitrogen containing fully saturated bicyclic ring, or an spirocyclic fully saturated ring system containing one or two nitrogen atoms, R<SUP>2</SUP> is hydrogen, lower alkenyl or alkyl, R<SUP>3</SUP> is alkyl which is unsubstituted or mono-, di- or trisubstituted by halogen; alkenyl or aryl, and their salts; processes for their preparation, their application in the treatment of the human or animal body, the use thereof - alone or in combination with one or more other pharmaceutically active compounds - for the treatment of diseases, a method for the treatment of such a disease and the use of such a compound - alone or in combination with one or more other pharmaceutically active compounds - for the manufacture of a pharmaceutical preparation for the treatment of a proliferative disease. |
申请人 |
NOVARTIS AG;NOVARTIS PHARMA GMBH;CAPRARO, HANS-GEORG;COUPEZ, BERNARD;FURET, PASCAL;MANLEY, PAUL, W.;PISSOT SOLDERMANN, CAROLE |
发明人 |
CAPRARO, HANS-GEORG;COUPEZ, BERNARD;FURET, PASCAL;MANLEY, PAUL, W.;PISSOT SOLDERMANN, CAROLE |